Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 for postoperative pain after bunionectomy
NCT03718039Phase 2Completed
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of bupivacaine + meloxicam in postoperative pain (3 arms), sponsored by Heron Therapeutics, Inc. Primary endpoint: Mean Area Under the Curve of the NRS-A Pain Intensity Scores at 72 hours. Started Oct 2018; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03718039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03718039.